In premenopausal women, a risk of ovarian malignancy algorithm (ROMA) value of 1.14 or greater indicates a high risk of finding epithelial ovarian cancer, whereas a ROMA value less than 1.14 …

For women who present with a pelvic mass, the Risk of Ovarian Malignancy Algorithm (ROMA) combines CA125 and HE4 with menopausal status for improved risk stratification.

Three multimarker serum-based tests specific to ovarian cancer have been cleared by the Food and Drug Administration (FDA) with the intended use of triaging patients with adnexal masses. They are …

Diagnostic Performance of ROMA and Biomarkers in Ovarian Cancer: A Systematic Review of Sensitivity, Specificity, and Menopausal Influence

Abstract: Objective: We aimed to compare the clinical utility and diagnostic accuracy of the AD-NEX model, ROMA score, RMI I, and RMI IV, as well as two serum markers (CA125 and HE4) in...

The EU-level policies for addressing Roma exclusion and deprivations are set out in the EU Roma strategic framework for equality, inclusion and participation (referred to hereafter as the EU Roma …

Evaluate current program services and determine effectiveness to meet needs (based on recent program performance). For the top 3-5 needs identified in your most recent community needs …